Medytox Solutions Inc. Announces 10-Q Filing 2nd Qtr. 2013 Profits

Marketwired

WEST PALM BEACH, FL--(Marketwired - August 16, 2013) - Medytox Solutions Inc. (MMMS) announces it has filed its 10-Q with the SEC for the 2nd Quarter of 2013 and for the 6 months ended June 30, 2013.

2013 second quarter revenues were $8,602,577 compared to $2,352,360 for the 2ndquarter of 2012, an increase of $6,250,217, or 266%. 

The Company reports revenues of $16,626,336, for the six months ended June 30, 2013, compared to $3,591,341 for the 6 months ended June 30, 2012, an increase of $13,034,995, or 363%.

Income (loss) from Operations, excluding depreciation and amortization and excluding one-time legal fees related to disputed subsidiary, were $2,978,567 for the six months ended June 30, 2013, compared to ($1,421,670) for the 6 months ended June 30, 2012.

This press release may contain "forward-looking" statements, as defined in the Private Securities Litigation Reform Act of 1995, as amended. Any such statements are made pursuant to the safe-harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, and they involve a number of risks and uncertainties that could cause actual results to differ materially from those that may be anticipated by or from the forward-looking statements. Important factors that could cause such a difference are set forth in the Company's filings with the Securities and Exchange Commission and include, but are not limited to, the ability of the Company to continue to successfully expand its business, the availability of suitable acquisition candidates, the ability of the Company to consummate any future acquisitions and future economic, competitive and market conditions and future business decisions

Contact:
CONTACT: 
Medytox
William Forhan
CEO
561-855-1621 
BForhan@MedytoxSolutionsInc.com
Site: www.MedytoxSolutionsInc.com
400 South Australian Ave * 8th Floor
* West Palm Beach, FL. * 33401
www.MedytoxSolutionsInc.com
View Comments (0)